Sodium-glucose cotransporter-2 inhibitors and the risk of gout: a Danish population based cohort study and symmetry analysis
While this connection is still being researched, one tiny 2019 study found that people taking GLP-1s, particularly women, reported that the medication changed the kind of foods they preferred
Start anti-nausea medication proactively in week 4 before peak symptoms hit in weeks 6-8 rather than waiting until youre miserable
There are several different GLP-1 medications currently approved for weight loss in people with obesity, including: Liraglutide and semaglutide are GLP-1 receptor agonist medications, while tirzepatide is a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist medication
Sources & Medical References The New England Journal of Medicine (NEJM): Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
The angle of your needle, the speed of injection, the volume of water you choose, the way you dissolve the powder, even the temperature of the vials before you start